Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Depreciation & Amortization (CF): 2022-2025

Historic Depreciation & Amortization (CF) for MDxHealth (MDXH) over the last 4 years, with Sep 2025 value amounting to $957,000.

  • MDxHealth's Depreciation & Amortization (CF) rose 16.57% to $957,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year increase of 160.21%. This contributed to the annual value of $3.1 million for FY2024, which is 32.52% up from last year.
  • Per MDxHealth's latest filing, its Depreciation & Amortization (CF) stood at $957,000 for Q3 2025, which was up 1.16% from $946,000 recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Depreciation & Amortization (CF) peaked at $957,000 during Q3 2025, and registered a low of -$8.4 million during Q4 2023.
  • For the 3-year period, MDxHealth's Depreciation & Amortization (CF) averaged around -$304,875, with its median value being $842,000 (2024).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first fell by 25.56% in 2023, then soared by 110.27% in 2024.
  • MRQ analysis of 4 years shows MDxHealth's Depreciation & Amortization (CF) stood at -$6.7 million in 2022, then decreased by 25.56% to -$8.4 million in 2023, then soared by 110.27% to $863,000 in 2024, then increased by 10.89% to $957,000 in 2025.
  • Its Depreciation & Amortization (CF) was $957,000 in Q3 2025, compared to $946,000 in Q2 2025 and $925,000 in Q1 2025.